Endometriosis increases the risk of cardiovascular events.
Nuvation pauses BET inhibitor plans after checking out interim Phase 1 data
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS